16.50 0.01 (0.06%)

Near 52W Low of $15.76

135.8K XNYS Volume

XNYS 28 Mar, 2025 5:30 PM (EDT)



Insider Trading disclosures for Tekla Healthcare Investors

The latest disclosure was made by Rose DiMartino in Tekla Healthcare Investors where a trade of 1,000 Common Stock done at an average price of $18.9 was reported to US exchanges on July 16, 2024.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Rose DiMartino Director Purchase of securities on an exchange or from another person at price $ 18.88 per share. 16 Jul 2024 1,000 1,000 (0%) 0% 18.9 18,880 Common Stock
Kathleen L. Goetz Director Purchase of securities on an exchange or from another person at price $ 16.42 per share. 09 Apr 2024 525 1,079 (0%) 0% 16.4 8,622 Common Stock
Todd Reit Director Purchase of securities on an exchange or from another person at price $ 16.93 per share. 02 Jan 2024 1,000 1,000 (0%) 0% 16.9 16,929 Common Stock
C. Maher William Director Purchase of securities on an exchange or from another person at price $ 16.58 per share. 28 Dec 2023 1,000 1,000 (0%) 0% 16.6 16,580 Common Stock
Goodson Alan Vice President Purchase of securities on an exchange or from another person at price $ 16.13 per share. 21 Dec 2023 170 170 (0%) 0% 16.1 2,742 Common stock
Daniel R. Omstead Director, President Purchase of securities on an exchange or from another person at price $ 15.63 per share. 25 Sep 2023 9,500 178,268 (0%) 0% 15.6 148,515 Shares of Beneficial Interest
Daniel R. Omstead Director, President Purchase of securities on an exchange or from another person at price $ 15.88 per share. 20 Sep 2023 9,500 168,768 (0%) 0% 15.9 150,829 Shares of Beneficial Interest
Kathleen Goetz Director Purchase of securities on an exchange or from another person at price $ 20.56 per share. 23 Mar 2022 73 554 (0%) 0% 20.6 1,501 Shares of Beneficial Interest
Kathleen Goetz Director Purchase of securities on an exchange or from another person at price $ 21.52 per share. 26 Jan 2022 481 481 (0%) 0% 21.5 10,349 Shares of Beneficial Interest
Daniel R. Omstead Director, President Purchase of securities on an exchange or from another person at price $ 20.68 per share. 21 Oct 2020 5,050 120,211 (0%) 0% 20.7 104,427 Shares of Beneficial Interest
Daniel R. Omstead Director, President Purchase of securities on an exchange or from another person at price $ 21.01 per share. 21 May 2020 5,000 110,357 (0%) 0% 21.0 105,054 Shares of Beneficial Interest
Daniel R. Omstead Director, President Purchase of securities on an exchange or from another person at price $ 16.24 per share. 17 Mar 2020 6,800 102,318 (0%) 0% 16.2 110,412 Shares of Beneficial Interest
Daniel R. Omstead Director, President Purchase of securities on an exchange or from another person at price $ 17.14 per share. 26 Dec 2018 6,300 85,406 (0%) 0% 17.1 107,971 Shares of Beneficial Interest
Daniel R. Omstead Director, President Purchase of securities on an exchange or from another person at price $ 20.43 per share. 25 Oct 2018 5,500 79,106 (0%) 0% 20.4 112,344 Shares of Beneficial Interest
Daniel R. Omstead Director, President Purchase of securities on an exchange or from another person at price $ 21.78 per share. 17 Oct 2018 3,882 73,606 (0%) 0% 21.8 84,534 Shares of Beneficial Interest
Thomas M. Kent None Purchase of securities on an exchange or from another person at price $ 24.19 per share. 25 Jan 2018 1,100 1,100 (0%) 0% 24.2 26,605 Shares of Beneficial Interest
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures